Appendix Table G-4Table with network sidesplits: Withdrawals due to adverse events

Drug ADrug BDirect Coefficient95% CIpIndirect Coefficient95% CIpCoefficient Difference95% CIp
AbataceptAbatacept+MTX−1.48−2.26, −0.70<0.0010.44−1.43, 2.320.644−1.92−4.15, 0.310.091
Infliximab+ MTXMethylprednisolone+ MTX−1.10−4.22, 2.030.491−1.26−7.68, 5.170.7020.16−6.23, 6.550.962

CI = confidence interval; MTX = methotrexate

From: Appendix G, Tests of Consistency for Main Network Meta-Analyses

Cover of Drug Therapy for Early Rheumatoid Arthritis: A Systematic Review Update
Drug Therapy for Early Rheumatoid Arthritis: A Systematic Review Update [Internet].
Comparative Effectiveness Review, No. 211.
Donahue KE, Gartlehner G, Schulman ER, et al.
Copyright Notice

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.